overall survival endpoint

Advertisement

cGxPJobs Banner

SELLAS Updates Phase 3 REGAL Trial in AML

NEW YORK, December 29, 2025 — SELLAS Life Sciences Group has provided a key update on its pivotal Phase...

By cGxPwire Editor
December 30, 2025

Read More

Advertisement

cGxPJobs

Directory